Browse by Track

(ASPOT01) Validity of the ICD-10-CM diagnosis code to identify patients with COVID-19 in Medicare administrative claims data

(ASPOT02) Contents of a Strong Real World Data Quality and Relevance Package for Regulatory or Health Technology Assessment Submission

(ASPOT03) The Value of Large Population-based Electronic Health Record and Insurance Claims Databases for Real-World Evidence Generation in Rare Diseases: a Systematic Literature Review

(ASPOT04) Use of Fluoroquinolones and Risk of Rhegmatogenous Retinal Detachment: A Retrospective Cohort Study Using Two National Representative Claims Data

(ASPOT05) Untangling National Medicaid Data: 30 Data Quality Metrics to Support Maternal Health Studies in Two Common Data Models

(ASPOT06) Comorbidity associated with COVID-19 hospitalisation among 135,000 children and adolescents with SARS-CoV-2 infection during their initial COVID-19 vaccination campaign in Spain

(ASPOT07) Exploring sources of statistical heterogeneity in a multi-database observational study: results from a case study using EXACOS-CV

(ASPOT08) Towards a Framework to Describe Diversity of Real-World Data Sources: Findings from the DIVERSE Initiative

(ASPOT09) Development of a Machine Learning Prediction Model for COVID-19 Patient Outcome Using a Sequential Data-Based Patient Similarity Metric

(ASPOT10) Evaluation of drug hypersensitivity reactions documented in a new coded and structured hypersensitivity documentation tool with de-labeling function: A retrospective cohort study

(ASPOT12) External validation using real world data of a generative AI assisted medication-indication knowledge base

(ASPOT13) Patient Engagement and Adherence to Digital Tasks: WEARable Activity Tracker Study Exploring Rheumatoid Arthritis Patients’ Disease Activity using Patient-Reported Outcome Measures, Clinical Measures, and Biometric Sensor Data

(ASPOT15) Automation of study report abstract generation by Large Language Models, methodology and application example

(ASPOT17) Trends in concomitant prescribing of anticoagulants and antiseizure medications among people with stroke in the United Kingdom.

(ASPOT18) Antidepressant long-term and potential high-risk prescribing in two Scottish health boards: a cross-sectional analysis

(ASPOT19) How many people would be eligible for treatment with nasal esketamine in Denmark? A critical assessment of the definition of treatment-resistant depression

(ASPOT20) Population-level utilization of direct-acting antiviral agents and trends in hepatitis C related hospitalizations

(ASPOT21) Global trends in outpatient gabapentinoid utilization: A cross‐sectional analysis of 67 countries

(ASPOT22) Psychotropic medication use in Australian aged care before and after aged care reforms, 2018 and 2022

(ASPOT23) Trends in Use of Antipsychotics in Germany 2014–2023: A Nationwide Population-based Study

(ASPOT24) Cardiovascular Medicine Use in Adults with ADHD: A Nationwide Study in Australia

(ASPOT27) Risk of thyroid dysfunction associated with the concomitant use of amiodarone and sulfonylureas: a nationwide cohort study

(ASPOT28) The Economic Burden of Drug-Drug Interactions in an Older Population acutely admitted to Hospital in Ireland: A Propensity Score Pharmacoeconomic Analysis.

(ASPOT29) Drug-Drug Interactions in the Older Community-Dwelling Population: Findings from The Irish LongituDinal study on Ageing

(ASPOT32) Concomitant use of direct oral anticoagulants and pharmacokinetically-interacting antiarrhythmics and the risk of major bleeding in patients with non-valvular atrial fibrillation: population-based cohort study

(ASPOT33) Antimicrobial Resistance Patterns of Escherichia coli urine isolates in the greater Sydney community from 2008 to 2018: a Geospatial Analysis

(ASPOT34) Climate vulnerability and utilization of electricity-dependent durable medical equipment among Medicare beneficiaries in North Carolina

(ASPOT35) Geographical visualization of Antibiotic use and Escherichia coli Antibiotic resistance Patterns in the greater Sydney community from 2016 to 2018

(ASPOT37) Climate Impact of Intravenous versus Oral Antibiotics: A Comparative Waste Assessment

(ASPOT39) Antimicrobial Resistance of Escherichia coli and Anti-diabetics: A Multi-year Geospatial Analysis

(ASPOT40) Evaluating the intersection of climate vulnerability and cancer burden in North Carolina

(ASPOT41) Clinical and Adverse Outcomes Associated with Concomitant Use of CYP2D6-metabolized Opioids with Antidepressants in Older Nursing Home Residents—A Retrospective Cohort Study

(ASPOT42) Antiseizure Medications Use And the Risk Of Parkinson’s Disease: A 15-year Population-based Study

(ASPOT43) Fall risk increasing adverse reactions (FRIARs) and fracture risk: A nested case control study

(ASPOT44) De-Med: Developing a Tool for Identifying and Categorizing Potentially Inappropriate Medications in the Elderly Using Beers Criteria, STOPP, and FORTA - A Cross-Sectional Study

(ASPOT45) Higher dose antiviral therapy for herpes infections is associated with a risk of serious adverse events in older adults with chronic kidney disease

(ASPOT46) Comparative Effectiveness of Short Acting Opioid Escalation and Initiation of a Long-Acting Opioid in Nursing Home Residents

(ASPOT47) Utilization of Benzodiazepines in the U.S.: An Analysis of Medical Expenditure Panel Survey

(BSPOT01) Variation in the time to complete the primary COVID-19 vaccine series by race, ethnicity, and geography among older US adults

(BSPOT02) A prospective cohort study of risk factors associated with prostate cancer incidence in predominantly low-income Black Americans

(BSPOT03) Advancing Health Equity in Europe: A Framework of Diversity and Fairness in Pharmacoepidemiologic Research

(BSPOT04) Comparing the Risk of Metoprolol-Related Adverse Drug Events Between Women and Men with Heart Failure Using Effectiveness Outcomes as a Proxy: a Population-Based Cohort Study using CPRD

(BSPOT05) Interpreting Effect Estimates Across Racial and Ethnic Categories in Propensity Score-Based Analyses: An Application in US Medicare Beneficiaries Initiating Antidiabetic Medications

(BSPOT06) Racial diversity and multimodal safety assessments: limitations of spontaneous reports data and the importance of advancing race-based risk stratification capabilities in real world data

(BSPOT07) What we owe to patients: A systematic literature review into reporting of potential biases in clinical decision support tools that use AI to personalise care in viral hepatitis

(BSPOT08) Enhancing Early Detection of Medical Device Safety Signals: A Case Study of Implantable Cardioverter Defibrillator Leads

(BSPOT09) Hospital readmissions among patients with atrial fibrillation undergoing catheter ablation using ThermoCool SmartTouch/ThermoCool SmartTouch SF Catheter with CARTO 3 System versus TactiCath Catheter with EnSite System

(BSPOT11) Using Electronic Health Record Data and Neural Network to Predict 90-day Readmission after Peripheral Vascular Intervention: Can it Match and Augment the Capacity of Clinical Registry?

(BSPOT12) Racial and Ethnic Disparities in Robot-Assisted Radical Prostatectomy: Physician-level Mechanisms

(BSPOT13) Does an additional gold or silver alloy provide any benefit over copper-only intrauterine devices? Insights from the EURAS-LCS12 study

(BSPOT15) Transcatheter and Surgical Aortic Valve Implantation in the Management of Aortic Stenosis between 2010 and 2022: a French Nationwide Study

(BSPOT16) Paternal metformin use before pregnancy and risk of congenital malformations: a cross-national cohort study in Norway and Taiwan

(BSPOT17) Trajectories for migraine medication in pregnancy and neurodevelopmental outcomes in offspring - a nationwide registry-based study

(BSPOT18) Concomitant Use of Antidepressants and Benzodiazepines During Pregnancy and Associated Risk of Congenital Malformations in Offspring: Population Based Cohort study

(BSPOT19) Estimating the Risk of Gestational Diabetes Mellitus Associated With Antidepressant Continuation During Pregnancy Using a Treatment Decision Study Design

(BSPOT20) Prevalence and treatment of chronic hypertension during pregnancy in a U.S. cohort, 2008-2021

(BSPOT21) Changes in adverse event reporting of neurodevelopmental disorders after maternal valproate exposure, following a major scientific publication and regulatory decisions, a contribution of the ConcePTION project

(BSPOT22) Associations between Dose of Prescribed Opioid Analgesic Exposure During Pregnancy and Adverse Birth Outcomes and Early Mortality: A Population-Based Study

(BSPOT23) Evaluating performance and methodologies of machine learning and conventional pharmacoepidemiologic modeling to identify pregnant individuals at risk of giving birth to children with major congenital malformations

(BSPOT24) Data Mining for Adverse Events of Montelukast in Children and Adolescents: A Tree-Based Scan Statistics Analysis of Swedish Nationwide Data

(BSPOT25) Proton Pump Inhibitors Use and Risk of Inflammatory Bowel Disease in Children: A Population-based Cohort Study

(BSPOT26) Association between childhood exposure to nuclear medicine and the risk of malignancy: sibling control and population-based cohort study

(BSPOT27) Severe Cutaneous Adverse Reactions Associated with Antibiotics in Pediatric Patients

(BSPOT28) How far can we go with Federated Meta-Analytic Approaches in Rare Diseases and Special Populations: A Case Example in Pediatric Pulmonary Arterial Hypertension for Regulatory Purposes

(BSPOT29) Trends in the prescribing of controlled substances to children and young adults enrolled in Medicaid, 2001-2019

(BSPOT30) Pediatric Utilization of New Molecular Entities (NMEs): A Summary of Early Post-marketing Uptake in the Sentinel Distributed Database

(BSPOT31) Real-world Research on Drug Safety Based on Quantitative Structure-Activity Relationship: A Case Study on Pediatric Drug-Induced Immune Thrombocytopenia

(BSPOT32) Important Tool in our Rare Disease Toolbox: Hybrid Retrospective-Prospective Natural History Studies Serve Well as External Comparators for Rare Disease Studies

(BSPOT33) Natural history of dermatomyositis and polymyositis in adults and paediatric populations: a network cohort study part of DARWIN EU®

(BSPOT34) Characteristics of Patients with ATTR Amyloidosis and Methodological Approaches for Establishing Clinical Subtype in the Netherlands

(BSPOT35) Leverage of an EHR Database to Estimate Prevalence and Incidence of Lymphatic Malformations (a Rare Disease) in the UK

(BSPOT36) Assessing Clinical Evidence for the Incorporation of Technologies in Ultra-rare Diseases in Brazil: A Decade of CONITEC Reports

(BSPOT37) Identifying women of childbearing age with Multiple Sclerosis in six European healthcare data sources - A contribution from the IMI-ConcePTION project

(BSPOT38) Estimating period prevalence: comparing methods to describe a rare disease population

(BSPOT39) Building Patient Journeys for Prader-Willi Syndrome Patients: Insights from Electronic Health Records Through Natural Language Processing

(BSPOT40) Incident benzodiazepine and Z-drug use and subsequent risk of serious infections

(BSPOT41) Current Applications of Machine Learning for Causal Inference in Healthcare Research using Observational Data

(BSPOT42) Signal Detection using Real World Data - Anticipating Serious Outcomes in Cancer Patients through Thresholds Ranges derived from US-based Claims Data

(BSPOT43) Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: a nationwide retrospective cohort study with a non-inferiority primary objective.

(BSPOT44) Real-World Trends in SARS-CoV-2 Antibody Levels and Their Link to Subsequent COVID-19 in the United States

(BSPOT45) High-throughput sequence symmetry analysis to detect Beta-Blocker induced prescribing cascades

(BSPOT46) Tree-based Scan Statistics to Identify Drug Repurposing Signals: a Test Case using Sodium-Glucose Cotransporter-2 Inhibitors

(BSPOT47) The Effect of Sodium Glucose Cotransporter-2 Inhibitors on HbA1c Variability and Acute Kidney Injury: A Causal Mediation Analysis

(BSPOT48) Effects of Sequential vs Single Pneumococcal Vaccination on Cardiovascular Diseases among Older Adults: a Population-based Cohort Study

(BSPOT49) Quality of and methodological heterogeneity in COVID-19 Vaccine safety studies – Case study of the myocarditis safety signal

(BSPOT50) Risk of New-Onset Seizures Following Immunization against COVID-19 in South Korea: A Self-Controlled Case-Series Study

(BSPOT51) Signal Monitoring for Adverse Events Following Immunization with COVID-19 Vaccines During the SARS-CoV-2 Pandemic: An Evaluation of the South African Surveillance System

(BSPOT52) Immunomodulatory treatment and immune responses to COVID-19 booster shots in patients with autoimmune rheumatic diseases: Results from the Covid-19 VaccinE Response in Rheumatology patients (COVER) study

(BSPOT53) Initial Observations on RSV Vaccine Use in Pregnant Patients

(BSPOT54) Special Populations Addressed in Vaccines Approved via the European Medicines Agency

(BSPOT55) Use of the Shingrix Vaccine Among Patients with Inflammatory Arthritis and Risk of Cardiovascular Events Following Herpes Zoster

(CSPOT01) Medication non-adherence and risk of mortality among patients with incident heart failure: a cohort study using the Clinical Practice Research Datalink (CPRD) Aurum database

(CSPOT02) Gender Differences in Statin Persistence across Racial and Ethnic Groups among Persons with HIV in the United States

(CSPOT04) Socioeconomic and demographic groups associated with adherence to antidiabetic medications in individuals with type 2 diabetes: A nationwide cohort study

(CSPOT05) Effect of long-acting injectable antipsychotics on treatment adherence and healthcare utilization in Chinese patients with schizophrenia: 1-year mirror-image study

(CSPOT06) Comparative Analysis of Treatment Discontinuation Among P2Y12 receptor inhibitors Post-Acute Coronary Syndrome: A Network Meta-analysis of Randomized Controlled Trials.

(CSPOT07) Factors Associated with Adherence to Long-Acting Injectable Antipsychotics Among Medicare Beneficiaries

(CSPOT08) The Relationships Between ADHD/ADHD Medication and the Persistence of Anti-Hypertensive Medication?

(CSPOT09) Evaluating the Association of Denosumab versus Bisphosphonates on Diabetes Risk: A Nationwide Cohort Study and Meta-Analysis

(CSPOT10) Effectiveness and Safety of SGLT2 Inhibitor Treatment on Renal Outcomes in Patients with Type 2 Diabetes: A Nationwide Observational Cohort Study in South Korea

(CSPOT12) Effectiveness of everolimus on transplant outcomes in Korean liver transplant recipients: a nationwide cohort study

(CSPOT14) Multinational prescribing trends of lithium from 2001 to 2019: a retrospective observational study using population-based databases from 17 countries and one special administrative region

(CSPOT16) Association Between Sacubitril/Valsartan and Risk of Dementia in Heart Failure Patients: A Nationwide Cohort Study

(CSPOT17) A post-authorization safety study of golimumab in ulcerative colitis using the Spanish ENEIDA registry (MK8259-042)

(CSPOT19) Tree-based mining of real-world data for potential safety signals associated with the use of dupilumab in the United States (2017-2023)

(CSPOT20) Adherence Differences Between Self-Administered and Provider-Administered Biologics Among Patients with Rheumatoid Arthritis During the COVID-19 National Emergency

(CSPOT21) The Risk of Venous Thromboembolism in Two of the Most Common Inflammatory Skin Diseases - a Comparative Cohort Study Consisting of the Adult Populations of Atopic Dermatitis and Psoriasis in the Swedish Specialist Care

(CSPOT23) An Active Safety Surveillance Using Real-World Evidence (ASSURE) Approach to Pharmacovigilance Signal Evaluation: The case of infliximab and alternative autoimmune conditions

(CSPOT24) Trajectories of adherence to biological drugs in patients with inflammatory bowel diseases: the VALORE project

(CSPOT25) Discrete Choice Experiment (DCE) as A Tool to Elicit Patient Preferences in A Complex Benefit-Risk Evaluation: A Rimonabant Case Study

(CSPOT27) A Comparative Analysis of Imposed Post-Authorization Measures for Advanced Therapy Medicinal Products Approved Between 2009-2013 in Europe and in United States of America

(CSPOT28) Limited impact of Direct Healthcare Professional Communications when using optimal outcomes and appropriate study populations: a systematic review.

(CSPOT29) Assessing use of the Reporting recommendation Intended for pharmaceutical Risk Minimization Evaluation Studies (RIMES) checklist in risk minimization evaluation studies in the EUPAS register

(CSPOT30) Identifying regulatory outcomes of Multi-Database and non- Multi-Database non-interventional Post Authorisation Safety Studies using publicly available information

(CSPOT31) Perspectives of People With Type 2 Diabetes Mellitus Towards a Decision Aid Assessing Preferences of Glucose-Lowering Drugs: The Dilemma of Choosing

(CSPOT32) Impact of risk communication on thrombosis with thrombocytopenia syndrome for COVID-19 adenovirus vector vaccines on European healthcare professionals

(CSPOT33) Incidence, Prevalence, and Survival of Breast Cancer in the United Kingdom from 2000-2021: A Population-Based Cohort Study

(CSPOT35) Live birth rate in female breast cancer survivors compared with the general population: matched cohort study using linked UK electronic health records

(CSPOT36) Real-world Treatment Pattern and Overall Survival of Stage III and IV Non‑Small‑Cell Lung Cancer Patients: An Analysis using German Cancer Registry Data

(CSPOT37) Use of anthracyclines and trastuzumab in breast cancer patients with comorbid cardiovascular disease in Sweden: a cross-sectional study

(CSPOT39) Trajectories of Antidepressant Use After Tamoxifen Initiation Among Young and Middle Age Women with Breast Cancer

(CSPOT40) Use and Outcomes of Trastuzumab Deruxtecan in HER2-positive and HER2-low Metastatic Breast Cancer in Real-World Setting: A Nationwide Cohort Study

(CSPOT41) Effectiveness of Axicabtagene Ciloleucel versus Conventional Treatments as First-line Therapy in Patients With High-risk Large B-cell Lymphoma: a Retrospective External Comparator Study

(CSPOT42) Stem Cell Therapy in Avascular Necrosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials

(CSPOT43) Risk Management of Authorised Advanced Therapy Medicinal Products in the EU

(CSPOT44) Planned and Ongoing EMA-mandated Post-approval Observational Studies of Cell & Gene Therapies (CGT): What Can We Learn from Study Characteristics?

(CSPOT45) Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase

(CSPOT46) Comparative Effectiveness of Denosumab versus Bisphosphonates among Treatment-Experienced Postmenopausal Women with Osteoporosis in the U.S. Medicare Program

(CSPOT47) Do Selective Serotonin Reuptake Inhibitors differ in depression treatment outcomes in Older Adults with Chronic Somatic Diseases? Evidence from a Danish Target Trial Emulation Study

(CSPOT48) Comparative Risk of Neurodevelopmental Disorders Between Children Exposed to β-lactam and non-β-lactam Antibiotics During Gestation: An Emulated Target Trial

(CSPOT49) Comparative Effectiveness of Denosumab versus Zoledronic Acid among Postmenopausal Women with Osteoporosis in the U.S. Medicare Program

(CSPOT50) No Elevated Risk of Cataract in Amiodarone Users: A Population-based Active-Comparator Study

(CSPOT51) Central vs. Non-central Angiotensin Converting Enzyme-inhibitors and the risk of Alzheimer's disease: A cohort study

(CSPOT53) Comparison of Anemia Outcomes between SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Patients with Chronic Kidney Disease: Multi-institutional Cohort Study with Target Trial Emulation in Taiwan